Literature DB >> 21484499

The ethics of moral compromise for stem cell research policy.

Zubin Master1, G K D Crozier.   

Abstract

In the US, stem cell research is at a moral impasse-many see this research as ethically mandated due to its potential for ameliorating major diseases, while others see this research as ethically impermissible because it typically involves the destruction of embryos and use of ova from women. Because their creation does not require embryos or ova, induced pluripotent stem cells offer the most promising path for addressing the main ethical objections to stem cell research; however, this technology is still in development. In order for scientists to advance induced pluripotent stem cell research to a point of translational readiness, they must continue to use ova and embryos in the interim. How then are we to ethically move forward with stem cell research? We argue that there is personal integrity and value in adopting a 'moral compromise' as a means for moving past the moral impasse in stem cell research. In a moral compromise, each party concedes part of their desired outcome in order to engage in a process that respects the values and desires of all parties equitably. Whereas some contend that moral compromise in stem cell research necessarily involves self-contradiction or loss of personal integrity, we argue that in the US context, stem cell research satisfies many of the key pre-conditions of an effective moral compromise. To illustrate our point, we offer a model solution wherein eggs and embryos are temporarily used until non-egg and non-embryonic sources of pluripotent stem cells are developed to a state of translational readiness.

Entities:  

Mesh:

Year:  2012        PMID: 21484499     DOI: 10.1007/s10728-011-0171-2

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  45 in total

1.  Embryonic stem-cell gametes: the new frontier in human reproduction.

Authors:  Zubin Master
Journal:  Hum Reprod       Date:  2005-12-16       Impact factor: 6.918

2.  New advances in iPS cell research do not obviate the need for human embryonic stem cells.

Authors:  Insoo Hyun; Konrad Hochedlinger; Rudolf Jaenisch; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

3.  Symbolism and sacredness of human parthenotes.

Authors:  Zubin Master; G K D Crozier
Journal:  Am J Bioeth       Date:  2011-03       Impact factor: 11.229

4.  Efficient and rapid generation of induced pluripotent stem cells using an alternative culture medium.

Authors:  Xiao-Yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-Long Guo; Xiang Wang; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Cell Res       Date:  2010-02-16       Impact factor: 25.617

5.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

6.  Human embryonic stem cell research: why the discarded-created-distinction cannot be based on the potentiality argument.

Authors:  Katrien Devolder
Journal:  Bioethics       Date:  2005-04       Impact factor: 1.898

Review 7.  Differentiation of germ cells and gametes from stem cells.

Authors:  A I Marques-Mari; O Lacham-Kaplan; J V Medrano; A Pellicer; C Simón
Journal:  Hum Reprod Update       Date:  2009-01-28       Impact factor: 15.610

8.  Human stem cell ethics: beyond the embryo.

Authors:  Jeremy Sugarman
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

9.  What about the women? Ethical and policy aspects of egg supply for cloning research.

Authors:  Katrina George
Journal:  Reprod Biomed Online       Date:  2007-08       Impact factor: 3.828

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  2 in total

1.  Impedance of novel therapeutic technologies: the case of stem cells.

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Clin Transl Sci       Date:  2012-06-28       Impact factor: 4.689

2.  Promoting public trust: ESCROs won't fix the problem of stem cell tourism.

Authors:  Zubin Master; David B Resnik
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.